235 related articles for article (PubMed ID: 29274627)
21. Quinacrine Inhibits ICAM-1 Transcription by Blocking DNA Binding of the NF-κB Subunit p65 and Sensitizes Human Lung Adenocarcinoma A549 Cells to TNF-α and the Fas Ligand.
Harada M; Morimoto K; Kondo T; Hiramatsu R; Okina Y; Muko R; Matsuda I; Kataoka T
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29207489
[TBL] [Abstract][Full Text] [Related]
22. Elevated Expression of Nrf-2 and ABCG2 Involved in Multi-drug Resistance of Lung Cancer SP Cells.
Yang B; Ma YF; Liu Y
Drug Res (Stuttg); 2015 Oct; 65(10):526-31. PubMed ID: 25368906
[TBL] [Abstract][Full Text] [Related]
23. Arsenic trioxide co-exposure potentiates benzo(a)pyrene genotoxicity by enhancing the oxidative stress in human lung adenocarcinoma cell.
Chen C; Jiang X; Ren Y; Zhang Z
Biol Trace Elem Res; 2013 Dec; 156(1-3):338-49. PubMed ID: 24061964
[TBL] [Abstract][Full Text] [Related]
24. Role of GSTP1-1 in mediating the effect of As2O3 in the Acute Promyelocytic Leukemia cell line NB4.
Bernardini S; Nuccetelli M; Noguera NI; Bellincampi L; Lunghi P; Bonati A; Mann K; Miller WH; Federici G; Lo Coco F
Ann Hematol; 2006 Oct; 85(10):681-7. PubMed ID: 16733740
[TBL] [Abstract][Full Text] [Related]
25. [miR-155/BACH1 Signaling Pathway in Human Lung Adenocarcinoma Cell Death Induced by Arsenic Trioxide].
Gu SY; Chen HY; Dai HM; Li XY; Zhang ZZ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Nov; 48(6):828-833. PubMed ID: 29260515
[TBL] [Abstract][Full Text] [Related]
26. Resistance of human multidrug resistance-associated protein 1-overexpressing lung tumor cells to the anticancer drug arsenic trioxide.
Vernhet L; Allain N; Payen L; Anger JP; Guillouzo A; Fardel O
Biochem Pharmacol; 2001 Jun; 61(11):1387-91. PubMed ID: 11331074
[TBL] [Abstract][Full Text] [Related]
27. Sulindac enhances arsenic trioxide-mediated apoptosis by inhibition of NF-kappaB in HCT116 colon cancer cells.
Lee HR; Cheong HJ; Kim SJ; Lee NS; Park HS; Won JH
Oncol Rep; 2008 Jul; 20(1):41-7. PubMed ID: 18575716
[TBL] [Abstract][Full Text] [Related]
28. Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer.
Maeda H; Hori S; Nishitoh H; Ichijo H; Ogawa O; Kakehi Y; Kakizuka A
Cancer Res; 2001 Jul; 61(14):5432-40. PubMed ID: 11454688
[TBL] [Abstract][Full Text] [Related]
29. Inhibition on LS-174T cell growth and activity of telomerase in vitro and in vivo by arsenic trioxide.
Wang X; Wang G; Dong D; Fu S; Yang B
Exp Toxicol Pathol; 2008 Sep; 60(6):481-8. PubMed ID: 18606528
[TBL] [Abstract][Full Text] [Related]
30. Arsenic trioxide induces apoptosis and the formation of reactive oxygen species in rat glioma cells.
Sun Y; Wang C; Wang L; Dai Z; Yang K
Cell Mol Biol Lett; 2018; 23():13. PubMed ID: 29610575
[TBL] [Abstract][Full Text] [Related]
31. Arsenic trioxide therapy for relapsed acute promyelocytic leukemia: an useful salvage therapy.
Huan SY; Yang CH; Chen YC
Leuk Lymphoma; 2000 Jul; 38(3-4):283-93. PubMed ID: 10830735
[TBL] [Abstract][Full Text] [Related]
32. MicroRNAs contribute to promyelocyte apoptosis in As2O3-treated APL cells.
Liang H; Li X; Wang L; Yu S; Xu Z; Gu Y; Pan Z; Li T; Hu M; Cui H; Liu X; Zhang Y; Xu C; Guo R; Lu Y; Yang B; Shan H
Cell Physiol Biochem; 2013; 32(6):1818-29. PubMed ID: 24356076
[TBL] [Abstract][Full Text] [Related]
33. Omega-3 and omega-6 polyunsaturated fatty acids enhance arsenic trioxide efficacy in arsenic trioxide-resistant leukemic and solid tumor cells.
Wirtitsch M; Roth E; Bachleitner-Hofmann T; Wessner B; Sturlan S
Oncol Res; 2009; 18(2-3):83-94. PubMed ID: 20066898
[TBL] [Abstract][Full Text] [Related]
34. Hypermethylation of ATP-binding cassette B1 (ABCB1) multidrug resistance 1 (MDR1) is associated with cisplatin resistance in the A549 lung adenocarcinoma cell line.
Li A; Song J; Lai Q; Liu B; Wang H; Xu Y; Feng X; Sun X; Du Z
Int J Exp Pathol; 2016 Dec; 97(6):412-421. PubMed ID: 27995666
[TBL] [Abstract][Full Text] [Related]
35. The effects of arsenic trioxide (As2O3) on human megakaryocytic leukemia cell lines. With a comparison of its effects on other cell lineages.
Alemany M; Levin J
Leuk Lymphoma; 2000 Jun; 38(1-2):153-63. PubMed ID: 10811458
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of TGF-β/SMAD3/NF-κB signaling by microRNA-491 is involved in arsenic trioxide-induced anti-angiogenesis in hepatocellular carcinoma cells.
Jiang F; Wang X; Liu Q; Shen J; Li Z; Li Y; Zhang J
Toxicol Lett; 2014 Nov; 231(1):55-61. PubMed ID: 25196641
[TBL] [Abstract][Full Text] [Related]
37. Arsenic trioxide: acute promyelocytic leukemia and beyond.
Bachleitner-Hofmann T; Kees M; Gisslinger H
Leuk Lymphoma; 2002 Aug; 43(8):1535-40. PubMed ID: 12400595
[TBL] [Abstract][Full Text] [Related]
38. Arsenic trioxide inhibits breast cancer cell growth via microRNA-328/hERG pathway in MCF-7 cells.
Wang Y; Wang L; Yin C; An B; Hao Y; Wei T; Li L; Song G
Mol Med Rep; 2015 Jul; 12(1):1233-8. PubMed ID: 25824027
[TBL] [Abstract][Full Text] [Related]
39. Cholesterol reduces the sensitivity to platinum-based chemotherapy via upregulating ABCG2 in lung adenocarcinoma.
Wu Y; Si R; Tang H; He Z; Zhu H; Wang L; Fan Y; Xia S; He Z; Wang Q
Biochem Biophys Res Commun; 2015 Feb; 457(4):614-20. PubMed ID: 25603057
[TBL] [Abstract][Full Text] [Related]
40. Autophagy plays a pro-apoptotic role in arsenic trioxide-induced cell death of liver cancer.
Deng ZT; Liang SF; Huang GK; Wang YQ; Tu XY; Zhang YN; Li S; Liu T; Cheng BB
J Integr Med; 2024 May; 22(3):295-302. PubMed ID: 38599914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
